According to researchers, the existing treatment for Alzheimer's is aimed at amyloid 'plaques', it has not been able to provide a clear map of how the degeneration will progress
The study was conducted by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and the University of Pittsburgh School of Medicine